Research ArticleArticle
Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
ESI MORGAN DEWITT, YANHONG LI, JEFFREY R. CURTIS, HENRY A. GLICK, JEFFREY D. GREENBERG, KEVIN J. ANSTROM, JOEL M. KREMER, GEORGE REED, KEVIN A. SCHULMAN and SHELBY D. REED
The Journal of Rheumatology February 2013, 40 (2) 127-136; DOI: https://doi.org/10.3899/jrheum.120400
ESI MORGAN DEWITT
From the Division of Rheumatology, James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Division of General Internal Medicine, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania; New York University Hospital for Joint Disease, New York, New York; Center for Rheumatology, Albany Medical College, Albany, New York; and the Division of Preventive and Behavioral Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts,
USA.
YANHONG LI
JEFFREY R. CURTIS
HENRY A. GLICK
JEFFREY D. GREENBERG
KEVIN J. ANSTROM
JOEL M. KREMER
GEORGE REED
KEVIN A. SCHULMAN
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Southwood TR,
- Foster HE,
- Davidson JE,
- Hyrich KL,
- Cotter CB,
- Wedderburn LR,
- et al.
- 4.↵
- Greenberg JD,
- Reed G,
- Decktor D,
- Harrold L,
- Furst D,
- Gibbously A,
- et al.
- 5.↵
- 6.↵
- Aletaha D,
- Smolen J
- 7.↵
- 8.↵
- 9.↵
- Anderson J,
- Sayles H,
- Curtis JR,
- Wolfe F,
- Michaud K
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- Rosenbaum PR,
- Rubin DB
- 14.↵
- Curtis JR,
- Reed G,
- Allison JJ,
- Moreland LW,
- Saag KG
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- Nam JL,
- Winthrop KL,
- van Vollenhoven RF,
- Pavelka K,
- Valesini G,
- Hensor EM,
- et al.
- 20.↵
- 21.↵
- Rubin DB
- 22.↵
- Sturmer T,
- Joshi M,
- Glynn RJ,
- Avorn J,
- Rothman KJ,
- Schneeweiss S
- 23.↵
- Gartlehner G,
- Hansen RA,
- Jonas BL,
- Thieda P,
- Lohr KN
In this issue
The Journal of Rheumatology
Vol. 40, Issue 2
1 Feb 2013
Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
ESI MORGAN DEWITT, YANHONG LI, JEFFREY R. CURTIS, HENRY A. GLICK, JEFFREY D. GREENBERG, KEVIN J. ANSTROM, JOEL M. KREMER, GEORGE REED, KEVIN A. SCHULMAN, SHELBY D. REED
The Journal of Rheumatology Feb 2013, 40 (2) 127-136; DOI: 10.3899/jrheum.120400
Comparative Effectiveness of Nonbiologic versus Biologic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis
ESI MORGAN DEWITT, YANHONG LI, JEFFREY R. CURTIS, HENRY A. GLICK, JEFFREY D. GREENBERG, KEVIN J. ANSTROM, JOEL M. KREMER, GEORGE REED, KEVIN A. SCHULMAN, SHELBY D. REED
The Journal of Rheumatology Feb 2013, 40 (2) 127-136; DOI: 10.3899/jrheum.120400